Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
3.
Org Lett ; 5(16): 2837-9, 2003 Aug 07.
Article in English | MEDLINE | ID: mdl-12889887

ABSTRACT

[reaction: see text] Construction and characterization of the C-glycosidic moiety of telomerase inhibitor D8646-2-6 (1) are described. This is the first example of the C-glycosylation using electron-poor aromatics, 4-hydroxypyrone, as a glycosyl acceptor. The glycosylation reaction and base-promoted isomerization affords desired beta-C-glycoside in a 61% overall yield.


Subject(s)
Enzyme Inhibitors/chemical synthesis , Glycosides/chemistry , Glycosides/chemical synthesis , Telomerase/antagonists & inhibitors , Enzyme Inhibitors/chemistry
4.
Biol Pharm Bull ; 26(2): 229-32, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12576685

ABSTRACT

We report that the synthetic peptide Prp106-126 (KTNMKHMAGAAAAGAVVGGLG-COOH) and the reversed peptide Prp126-106 (GLGGVVAGAAAAGAMHKMNTK-COOH) of human prion (hPrp) can express the decarboxylase activity for oxaloacetate in the presence of trifluoroethanol, similar to that of Oxaldie 1 (LAKLLKALAKLLKK-CONH2) reported previously. The degree of the relative activity of Prp106-126 and Prp126-106 to Oxaldie 1 is 0.47 and 0.21, respectively. Based on this experimental result, we applied the informational system method (ISM) developed by Veljkovic et al. to the amino acid sequence of Prp106-126 and Prp126-106 to extract a common factor. The same spectra were obtained, indicating that the same periodicity may be conserved on their sequences, as a necessary factor for expressing the same biological activity, irrespective of the orientation of the primary sequence.


Subject(s)
Peptide Fragments/pharmacology , Prions/genetics , Prions/pharmacology , Amino Acid Sequence/drug effects , Amino Acid Sequence/physiology , Carboxy-Lyases/metabolism , Enzyme Activation/drug effects , Enzyme Activation/physiology , Humans , Molecular Sequence Data , Peptide Fragments/genetics , Peptide Fragments/pharmacokinetics , Prions/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...